Graham A. Mackay
Larbert, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Disease modifying treatments for Alzheimer's disease: Clinician perspectives.
Journal: Journal of Alzheimer's disease : JAD
Published: March 25, 2026
Direct protamine activation of human mast cells is MRGPRX2-dependent and is modulated by heparin.
Journal: The Journal of pharmacology and experimental therapeutics
Published: September 25, 2025
Pharmacology education: putting more SoTL (Scholarship of Teaching and Learning) in the bottle.
Journal: European journal of pharmacology
Published: September 25, 2025
Faecal haemoglobin-based referral and investigation prioritisation is associated with colorectal cancer-specific survival in symptomatic patients: a retrospective observational study.
Journal: British journal of cancer
Published: August 14, 2025
Paroxysmal Kinesigenic Dyskinesia Caused by 16p11.2 Microdeletion: A Case Report.
Journal: Case reports in neurology
Published: June 24, 2025
Lecanemab appropriate use recommendations for clinical practice in the UK.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 25, 2025
Differential MRGPRX2-dependent activation of human mast cells by polymyxins and octapeptins.
Journal: European journal of pharmacology
Published: June 30, 2024
Scottish Intercollegiate Guidelines Network Guidance on Dementia: The Investigation of Suspected Dementia (SIGN 168) with Focus on Biomarkers-Executive Summary.
Journal: Thrombosis and haemostasis
Published: May 24, 2024
National audit of pathways in epileptic seizure referrals (NAPIER): A national, multicentre audit of first seizure clinics throughout the UK and Ireland.
Journal: Seizure
Published: June 08, 2023
Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM).
Journal: The journal of allergy and clinical immunology. In practice
Published: January 27, 2022
The first reptilian allergen and major allergen for fish-allergic patients: Crocodile β-parvalbumin.
The first reptilian allergen and major allergen for fish-allergic patients: Crocodile β-parvalbumin.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: December 21, 2021
Last Updated: 09/26/2026